Literature DB >> 2412337

A study of antigenic variants of foot-and-mouth disease virus by polyacrylamide gel electrophoresis of their structural polypeptides.

N J Knowles, R S Hedger.   

Abstract

Twenty-nine foot-and-mouth disease (FMD) type A virus strains, previously classified serologically as distinct subtypes were analysed by polyacrylamide gel electrophoresis (PAGE) to determine the extent of variation in the pattern of the structural polypeptides and to evaluate the technique as an aid to existing subtyping techniques. The majority of the subtypes examined had distinct polypeptide patterns, however, some variation also occurred between strains within a subtype. The position of VP2(1B) and VP3(1C) was often unchanged in different strains within a subtype and between geographically related subtypes over long periods of time. Changes in the position of VP1(1D) were also observed within a subtype. The technique was considered to be of value for the screening of isolates prior to conventional serological subtyping procedures and in the tracing of the possible origin of FMD outbreaks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412337     DOI: 10.1016/0378-1135(85)90005-7

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

Review 1.  Development of foot-and-mouth disease virus strain characterisation--a review.

Authors:  R P Kitching; N J Knowles; A R Samuel; A I Donaldson
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

2.  Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera.

Authors:  E R Rojas; E Carrillo; M Schiappacassi; R Campos
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Serological and biochemical analysis of some recent type A foot-and-mouth disease virus isolates from the Middle East.

Authors:  A R Samuel; N J Knowles; R P Kitching
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.